Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Cancer refers to a group of complicated diseases which is one of the top two leading causes of death globally. Traditional chemotherapy and radiation ...

Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four multiple ascending dose ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

NIH-supported researchers have developed a new method using a protein from tardigrades to help protect healthy tissue during cancer radiation therapy, showing early promise in lab tests.

Mouse cells tweaked to produce the tardigrade protein incurred less DNA damage than unaltered cells — hinting at a new tool for cancer patient care.